Skip to main content
Caplight Logo









Menten AI

Menten AI

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://menten.ai/

Last Round

Seed

Jun 30, 2020

Est. Valuation

$2.14M

Total Funding Raised

$4.15M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Menten AI is a biotechnology company that develops generative AI and quantum computing technologies to design peptide macrocycles and proteins for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Quantum Computing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

cyclic peptide designdrug discovery platformAI drug discoveryquantum computingpreclinical drug discoverygenerative AIin silico drug designprotein-protein interactionsphysics-based modelingcomputational biologypeptide therapeuticsquantum drug discoverybiotech AIde novo designpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Menten AI Comparables

Compare Menten AI with similar companies based on industry and business-model similarity.

Menten AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vilya
87%
ProteinQure
87%
Ordaos Bio
87%

Menten AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 30, 2020
AcceleratorMar 18, 2020

Key People

Founding team and executive leadership

Hans Melo

Co-Founder And CEO

Founding Team

Menten AI Investors

Notable investors and investment history

Menten AI investors
InvestorRounds
Uncork CapitalSeed
Khosla VenturesSeed
Social Impact CapitalSeed
Y CombinatorSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 44% MoM.

  • Jan 1, 2026

    Launched MAUD 1.0 for AI-driven design of cyclic peptide medicines.

Menten AI Filings

Explore SEC and related filing metadata, where available.

Menten AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Menten AI's valuation, stock price, and market status.

Is Menten AI a public or private company?

Menten AI is a private company.

What is the current stock price of Menten AI?

Menten AI is a private company with no public stock price. No recent secondary market data is available.

How much is Menten AI worth (valuation)?

Valuation information for Menten AI is not publicly available.

Can I buy Menten AI stock?

Menten AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Menten AI's last funding round?

Menten AI's most recent funding round was Seed on June 30, 2020.

Who are the main investors in Menten AI?

Key investors in Menten AI include Uncork Capital, Khosla Ventures, Y Combinator.

Will Menten AI IPO soon?

No public IPO plans have been announced for Menten AI.

How can I track Menten AI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Menten AI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range13
Year Founded2018
Last FundingJun 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?